Medicine Supply Notification: Quinapril (Accupro® ) 5mg, 10mg, 20mg and 40mg tablets

Medicine Supply Notification: Quinapril (Accupro® ) 5mg, 10mg, 20mg and 40mg tablets

May 5, 2022

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Quinapril (Accupro®) 5mg, 10mg, 20mg and 40mg tablets.

MSN/2022/041

Tier 2 – medium impact

Date of issue 5th May 2022

  • All strengths of quinapril (Accupro®) tablets have been recalled with a resupply date to be confirmed. Pfizer are the sole supplier of quinapril tablets in the UK
  • Alternative ACE inhibitors remain available and can support an uplift in demand.

A copy of this medicine supply notification, including further information, has been sent to all pharmacy NHS email addresses.

DHSC and NHSE/I have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.

The Tool also details any changes to resupply dates and updates to the entries.

To access the Tool you will need  an NHS email address. Once set up and logged in, you will be able to access it online.

New shortages not listed on the SPS website, can be reported using our shortage reporting tool.



Posted in: ,


More Latest News >

HEE: Clinical Skills Training Survey

Health Education England (HEE) are seeking the views of frontline community pharmacists to support the development of further training modules that support pharmacists in the...

Drug Tariff Watch – June 2022

The Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below...

Have you completed the DMS DoC?

Pharmacists and pharmacy technicians are reminded that they must complete the Discharge Medicines Service (DMS) Declaration of Competence (DoC) before...